Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06544447
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction A Randomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective To evaluate the effect of transcutaneous auricular vagus nerve stimulation taVNS for the patients with dry eye disease with meibomian gland dysfunction
Methods We enrolled 270 patients at Beijing Tongren Hospital All treatments were self-administered by the patients at home after training at the hospital Patients completed questionnaires at baseline 1 month 3 months and 6 months
OSDI score TBUT OPAS NPSI-eye and Schirmer I expressibility and secretion score to evaluate the therapeutic effects A difference of P 005 was considered statistically significant
Methods We enrolled 270 patients at Beijing Tongren Hospital All treatments were self-administered by the patients at home after training at the hospital Patients completed questionnaires at baseline 1 month 3 months and 6 months
OSDI score TBUT OPAS NPSI-eye and Schirmer I expressibility and secretion score to evaluate the therapeutic effects A difference of P 005 was considered statistically significant
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None